Macular Edema after Successful Pars Plana Vitrectomy for Rhegmatogenous Retinal Detachment: Factors Affecting Edema Development and Considerations for Treatment

REFERENCES

• Nemet A, Moshiri A, Yiu G, Loewenstein A, Moisseiev E. A review of innovations in rhegmatogenous retinal detachment surgical techniques. J Ophthalmol. 2017;2017:4310643.
   PubMed Web of Science ®Google Scholar
• Ah-Fat FG, Sharma MC, Majid MA, Mcgalliard JN, Wong DQ. Trends in vitreoretinal surgery at a tertiary referral centre: 1987 to 1996. Br J Ophthalmol. 1999;83:396–398. doi:10.1136/bjo.83.4.396.
   PubMed Web of Science ®Google Scholar
• Yoshikawa Y, Shoji T, Kanno J, et al. Evaluation of microvascular changes in the macular area of eyes with rhegmatogenous retinal detachment without macular involvement using swept-source optical coherence tomography angiography. Clin Ophthalmol. 2018;12:2059–2067. doi:10.2147/OPTH.S177933.
   PubMed Web of Science ®Google Scholar
• Lobes LA, Grand MG. Incidence of cystoid macular edema following scleral buckling procedure. Arch Ophthalmol. 1980;98:1230–1232. doi:10.1001/archopht.1980.01020040082010.
   PubMedGoogle Scholar
• Tunc M, Lahey JM, Kearney JJ, Lewis JM, Francis R. Cystoid macular oedema following pneumatic retinopexy vs scleral buckling. Eye. 2007;21:831–834. doi:10.1038/sj.eye.6702431.
   PubMed Web of Science ®Google Scholar
• Miyake K, Miyake Y, Maekubo K, Asakura M, Manabe R. Incidence of cystoid macular edema after retinal detachment surgery and the use of topical indomethacin. Am J Ophthalmol. 1983;95:451–456. doi:10.1016/0002-9394(83)90264-7.
   PubMed Web of Science ®Google Scholar
• Valldeperas X, Romano MR, Romano M, Wong D. Resolution of cystoid macular oedema after retinal detachment repair: is intravitreal triamcinolone useful? Eye. 2006;20:1321–1322. doi:10.1038/sj.eye.6702188.
   PubMed Web of Science ®Google Scholar
• Romano V, Angi M, Scotti F, et al. Inflammation and macular oedema after pars plana vitrectomy. Mediators Inflammation. 2013;2013:971758.
   PubMed Web of Science ®Google Scholar
• Miyake K, Ibaraki N. Prostaglandins and cystoid macular edema. Surv Ophthalmol. 2002;47:S203–S218.
   PubMed Web of Science ®Google Scholar
• Thanos A, Todorich B, Yonekawa Y, et al. Dexamethasone intravitreal implant for the treatment of recalcitrant macular edema after rhegmatogenous retinal detachment repair. Retina. 2018;38:1084–1090. doi:10.1097/IAE.0000000000001720.
   PubMed Web of Science ®Google Scholar
• Bonnet M. Prognosis of cystoid macular edema after retinal detachment repair. Graefes Arch Clin Exp Ophthalmol. 1986;224:13–17.
   PubMed Web of Science ®Google Scholar
• Ackerman AL, Topilow HW. A reduced incidence of cystoid macular edema following retinal detachment surgery using diathermy. Ophthalmology. 1985;92:1092–1095. doi:10.1016/s0161-6420(85)33900-3.
   PubMed Web of Science ®Google Scholar
• Yang JY, Kim HK, Kim SH, Kim SS. Incidence and risk factors of cystoid macular edema after vitrectomy with silicone oil tamponade for retinal detachment. Korean J Ophthalmol. 2018;32:204–210. doi:10.3341/kjo.2017.0050.
   PubMedGoogle Scholar
• Bae SH, Hwang JS, Yu HG. Comparative analysis of macular microstructure by spectral-domain optical coherence tomography before and after silicone oil removal. Retina. 2012;32:1874–1883. doi:10.1097/IAE.0b013e318246907c.
   PubMed Web of Science ®Google Scholar
• Meredith TA, Reeser FH, Topping TM, Aaberg TM. Cystoid macular edema after retinal detachment surgery. Ophthalmology. 1980;87:1090–1095. doi:10.1016/s0161-6420(80)35114-2.
   PubMed Web of Science ®Google Scholar
• Bonnet M, Fernandez Pastor D. Rupture of the blood-retinal barrier after microsurgery of retinal detachment. Ophtalmologie. 1988;2:29–31.
   PubMedGoogle Scholar
• Gu R, Zhou M, Jiang C, Yu J, Xu G. Elevated concentration of cytokines in aqueous in post-vitrectomy eyes. Clin Exp Ophthalmol. 2016;44:128–134. doi:10.1111/ceo.12638.
   PubMed Web of Science ®Google Scholar
• Takahashi S, Adachi K, Suzuki Y, Maeno A, Nakazawa M. Profiles of inflammatory cytokines in the vitreous fluid from patients with rhegmatogenous retinal detachment and their correlations with clinical features. Biomed Res Int. 2016;2016:4256183. doi:10.1155/2016/4256183.
   PubMed Web of Science ®Google Scholar
• Pastor JC, Rojas J, Pastor-Idoate S, Di Lauro S, Gonzalez-Buendia L, Delgado-Tirado S. Proliferative vitreoretinopathy: a new concept of disease pathogenesis and practical consequences. Prog Retin Eye Res. 2016;51:125–155. doi:10.1016/j.preteyeres.2015.07.005.
   PubMed Web of Science ®Google Scholar
• Moysidis SN, Thanos A, Vavvas DG. Mechanisms of inflammation in proliferative vitreoretinopathy: from bench to bedside. Mediators Inflamm. 2012;2012:815937. doi:10.1155/2012/815937.
   PubMed Web of Science ®Google Scholar
• Jarrett WH. 2nd: rhematogenous retinal detachment complicated by severe intraocular inflammation, hypotony, and choroidal detachment. Trans Am Ophthalmol Soc. 1981;79:664–683.
   PubMedGoogle Scholar
• Aptel F, Colin C, Kaderli S, et al. Management of postoperative inflammation after cataract and complex ocular surgeries: a systematic review and Delphi survey. Br J Ophthalmol. 2017;101:1–10. doi:10.1136/bjophthalmol-2017-310324.
   PubMed Web of Science ®Google Scholar
• Boyer DS, Yoon YH, Belfort R Jr, et al. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology. 2014;121:1904–1914. doi:10.1016/j.ophtha.2014.04.024.
   PubMed Web of Science ®Google Scholar
• Haller JA, Bandello F, Belfort R Jr, et al. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology. 2011;118:2453–2460. doi:10.1016/j.ophtha.2011.05.014.
   PubMed Web of Science ®Google Scholar
• Lowder C, Belfort R Jr, Lightman S, et al. Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch Ophthalmol. 2011;129:545–553. doi:10.1001/archophthalmol.2010.339.
   PubMed Web of Science ®Google Scholar
• Bellocq D, Korobelnik JF, Burillon C, et al. Effectiveness and safety of dexamethasone implants for post-surgical macular oedema including Irvine-Gass syndrome: the EPISODIC study. Br J Ophthalmol. 2015;99:979–983. doi:10.1136/bjophthalmol-2014-306159.
   PubMed Web of Science ®Google Scholar
• Chang-Lin JE, Attar M, Acheampong AA, et al. Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant. Invest Ophthalmol Vis Sci. 2011;52:80–86. doi:10.1167/iovs.10-5285.
   PubMed Web of Science ®Google Scholar
• Klamann A, Böttcher K, Ackermann P, Geerling G, Schargus M, Guthoff R. Intravitreal dexamethasone implant for the treatment of postoperative macular edema. Ophthalmologica. 2016;236:181–185. doi:10.1159/000448057.
   PubMed Web of Science ®Google Scholar